コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tients (86%), of whom 7 (37%) had concurrent central nervous system lymphoma.
2 in radiotherapy improves survival in primary central nervous system lymphoma.
3 ts with early and potentially more treatable central nervous system lymphoma.
4 intraocular lymphoma (PIOL) is a subtype of central nervous system lymphoma.
5 ed for newly diagnosed and recurrent primary central nervous system lymphoma.
6 sease or as secondary involvement by primary central nervous system lymphoma.
7 to water- and lipid-soluble drugs in primary central nervous system lymphomas.
8 quired immunodeficiency syndrome and primary central nervous system lymphoma (AIDS-PCNSL) is due in p
9 of primary vitreoretinal lymphoma or primary central nervous system lymphoma and can regress spontane
10 virus DNA was found in 9 of 14 patients with central nervous system lymphoma and in 2 of 38 patients
11 ularly for responsive tumors such as primary central nervous system lymphoma and oligodendrogliomas.
12 individuals with low-grade gliomas, primary central nervous system lymphoma and those undergoing pro
13 ain tumor types (in particular, AIDS-related central nervous system lymphomas and nasopharyngeal carc
14 a, 5 (9%) Burkitt lymphoma, 10 (18%) primary central nervous system lymphoma, and 7 (13%) other non-H
15 fluid is useful in the diagnosis of primary central nervous system lymphoma, and monitoring of Epste
17 frequent responses in patients with primary central nervous system lymphoma but was associated with
18 treoretinal lymphoma (PVRL) without signs of central nervous system lymphoma (CNSL) involvement deter
20 t was found to be significantly increased in central nervous system lymphomas compared with glioblast
21 th uncommon histological variants of primary central nervous system lymphoma have been published.
22 ospinal fluid (CSF) in patients with primary central nervous system lymphoma; however, the CSF levels
23 ular lymphoma (PIOL) is a variant of primary central nervous system lymphoma in which lymphoma cells
24 e for treatment of PIOL or recurrent primary central nervous system lymphoma involving only the eyes
26 therapy for progressive or recurrent primary central nervous system lymphoma is an area of active int
36 dy for patients with newly diagnosed primary central nervous system lymphoma (PCNSL) using induction
37 rapy is the mainstay of treatment of primary central nervous system lymphoma (PCNSL), but relapses re
42 g the brain (cerebral toxoplasmosis, primary central nervous system lymphoma, progressive multifocal
43 However, the optimal management of primary central nervous system lymphoma remains to be defined, a
45 studies on the biology of recurrent primary central nervous system lymphoma should help to clarify t
46 ss has been made in the treatment of primary central nervous system lymphoma since the time when it w
47 uate whether the chemosensitivity of primary central nervous system lymphomas to water-soluble drugs
48 rimary vitreoretinal lymphoma and/or primary central nervous system lymphoma was made within 6 months
50 imary effusion lymphoma; 1 of 4 AIDS-primary central nervous system lymphoma), with 9 of 39 (23.1%) c
51 ognitive deficits among survivors of primary central nervous system lymphoma without residual tumor a
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。